| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 684409 | 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone | 0.029142074732756 | 0.21052059 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.029142074732756 | -0.20266906 |
| NSC 693037 | Null | 0.029142074732756 | 0.21288913 |
| NSC 693248 | Null | 0.029142074732756 | 0.16130615 |
| NSC 693322 | Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- | 0.029142074732756 | 0.065280671 |
| NSC 710326 | Null | 0.029142074732756 | -0.0048774707 |
| NSC 715407 | Null | 0.029142074732756 | 0.40586653 |
| NSC 718781 | Erlotinib hydrochloride | 0.029142074732756 | -0.44070338 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.029142074732756 | 0.23129085 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.029142074732756 | 0.16798774 |